Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc.verified

ELDN

Price:

$5.3

Market Cap:

$210.18M

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2...[Read more]

Industry

Biotechnology

IPO Date

2014-09-17

Stock Exchange

NASDAQ

Ticker

ELDN

The Enterprise Value as of November 2024 (TTM) for Eledon Pharmaceuticals, Inc. (ELDN) is 184.79M

According to Eledon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 184.79M. This represents a change of 248.21% compared to the average of 53.07M of the last 4 quarters.

Eledon Pharmaceuticals, Inc. (ELDN) Historical Enterprise Value (quarterly & annually)

How has ELDN Enterprise Value performed in the past?

The mean historical Enterprise Value of Eledon Pharmaceuticals, Inc. over the last ten years is 5.39M. The current 184.79M Enterprise Value has changed 342.80% with respect to the historical average. Over the past ten years (40 quarters), ELDN's Enterprise Value was at its highest in in the June 2015 quarter at 239.13M. The Enterprise Value was at its lowest in in the December 2020 quarter at -102950156.40.

Quarterly (TTM)
Annual

Average

5.39M

Median

-5760859.54

Minimum

-91698947.20

Maximum

172.04M

Eledon Pharmaceuticals, Inc. (ELDN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eledon Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.55%

Maximum Annual Enterprise Value = 172.04M

Minimum Annual Increase = -1838.06%

Minimum Annual Enterprise Value = -91698947.20

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202340.09M-273.58%
2022-23092620.8823.43%
2021-18709643.38-79.60%
2020-91698947.205.55%
2019-1623319.00-213.00%
20181.44M-18.29%
20171.76M-110.72%
2016-16407090.28-109.54%
2015172.04M-1838.06%
2014-9898400.08-102.97%

Eledon Pharmaceuticals, Inc. (ELDN) Average Enterprise Value

How has ELDN Enterprise Value performed in the past?

The current Enterprise Value of Eledon Pharmaceuticals, Inc. (ELDN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-572354.75

5-year avg

-19007866.09

10-year avg

5.39M

Eledon Pharmaceuticals, Inc. (ELDN) Enterprise Value vs. Peers

How is ELDN’s Enterprise Value compared to its peers?

Eledon Pharmaceuticals, Inc.’s Enterprise Value is less than Inozyme Pharma, Inc. (305.00M), less than Day One Biopharmaceuticals, Inc. (865.54M), less than Terns Pharmaceuticals, Inc. (494.74M), greater than HOOKIPA Pharma Inc. (-25962570.00), greater than X4 Pharmaceuticals, Inc. (18.46M), greater than Acumen Pharmaceuticals, Inc. (131.19M), less than Amylyx Pharmaceuticals, Inc. (312.13M), less than Mereo BioPharma Group plc (576.84M),

Build a custom stock screener for Eledon Pharmaceuticals, Inc. (ELDN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eledon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eledon Pharmaceuticals, Inc. (ELDN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eledon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Eledon Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Eledon Pharmaceuticals, Inc. (ELDN)?

What is the 3-year average Enterprise Value for Eledon Pharmaceuticals, Inc. (ELDN)?

What is the 5-year average Enterprise Value for Eledon Pharmaceuticals, Inc. (ELDN)?

How does the current Enterprise Value for Eledon Pharmaceuticals, Inc. (ELDN) compare to its historical average?